NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported 4 percent organic revenue growth amid a 5.5 percent drop in overall revenues for the third quarter. Caliper also noted that it narrowed its net loss for the quarter by 37 percent.

The Hopkinton, Mass.-based firm also said that it has been awarded a $1.8 million Phase II commitment from the Environmental Protection Agency to screen as many as 700 compounds against Caliper's ToxCast assay panel, but doesn't expect to realize this revenue until the first quarter of 2010.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.